This website uses cookies to help you make the most of your visit.
By continuing to browse without changing your settings, you agree to our use of cookies.
Give me more information
x
-->

Pharmacy inspections

Inspection reports and learning from inspections

Skip to Content (Press Enter)

Mosspark Pharmacy (1090494) - Improvement action plan

Standard not met Reason Action being taken by the Pharmacy By when Notification By Pharmacy Improvements Made
1.1

The pharmacy does not identify and manage all the risks for the services it provides. It has a basic documented written procedure for handling aesthetics prescriptions. But this does not address all aspects of the service, including higer-risk medicines such as injectable weight loss medicines and botulinum toxins. For example, it does not consider what additional information may be required to support the clinical check, such as using people's body mass index (BMI) to ensure weight loss injections are appropriate to supply. And what checks team member should make to ensure face-to-face consultations happen with prescribers for botulinum toxins.

Our internal weight management service records body mass index (BMI), blood pressure and blood glucose levels prior to one of our prescribers issuing a prescription and then having it dispensed in our pharmacy. However, we have never checked BMI as part of our clinical check for
GLP-1 agonist prescriptions. We can only ensure that the prescription is legally written and dose is appropriate for a patient of that age. For the few private prescriptions we do receive for GLP-1 agonists, we will request a BMI.

11/09/2025 23/10/2025
1.2

The pharmacy does not routinely audit or review the services it provides to ensure its processes are effective at keeping services safe. For example, it doesn't complete clinical audits of supplies to ensure they are appropriate and made in an appropriate timeframe. It doesn't have a process to monitor prescribers to show they continue to be eligible and safe to prescribe. And it doesn't carry out appropriate monitoring on the delivery of medicines that require temperature control. It does not have robust processes in place to identify trends and to prompt interventions. So, the pharmacy is unable to show how it continually monitors and improves the quality and safety of its services.

We will extend the audit used in our Healthcare Improvement Scotland (HIS) clinic for prescribers using our pharmacy for private prescriptions. This involves bi-annual check of (a) professional registration (b) indemnity
insurance (c) prescriber status.

11/09/2025 23/10/2025
1.6

The pharmacy records the details of the private prescriptions it supplies. But it does not always record accurate or complete information about prescribers, such as their name or address. This means the pharmacy does not keep the correct records as required by law.

The inspection has flagged a glitch within the software where prescriber detail is not always populated in the private script report. We are in discussion with the software provider to address this. It is also flagged that prescribers use various addresses on their prescriptions.
A new standard operating procedure (SOP) has been written to only allow this address to be a regulated premise ie HIS registered clinic, GP practice, NHS Dental practice, GPhC registered pharmacy

11/09/2025 23/10/2025
4.2

The pharmacy cannot demonstrate it always delivers its services safely. It does not have robust processes to ensure it always makes the appropriate checks when dispensing medicines. This includes ensuring prescribers have completed a face-to-face consultation to prescribe botulinum toxins. And obtaining the appropriate clinical information to provide injectable weight management medicines. It dispenses medicines against prescriptions without patient-specific directions, such as ‘Use as directed by the prescriber’. This makes it difficult to complete an appropriate clinical check of the prescription and people may not be aware how to use their medicines appropriately.

We will require Botox scripts written by a prescriber for another practitioner to
administer to include directions. We will also request that they confirm a face to face consultation has taken place, especially if they are prescribing for another practitioner to administer.

11/09/2025 23/10/2025
4.2

The pharmacy delivers some prescriptions to people for medicines that required cold storage. But it has not completed the necessary testing to ensure the packaging it uses appropriately maintains the correct temperature for these medicines. So, it cannot be sure these medicines remain suitable to use.

We have previously audited our delivery of cold-chain medicines as part of our wholesale distribution authorisation (WDA) application with Medicines and Healthcare Products Regulatory Agency (MHRA.) Our WDA license has now expired so a new audit will be conducted using the same methodology.

11/09/2025 23/10/2025